MICROM 301 Lecture Notes - Lecture 16: Hepatitis B Immune Globulin, Passive Immunity, Immunity (Medical)

29 views6 pages

magentawoodchuck590

29 Nov 2017

School

Department

Microbiology

Course

MICROM 301

Professor

Roger E.Bumgarner

For unlimited access to Class Notes, a Class+ subscription is required.

Document Summary

Immunization: process of inducing immunity, used to protect against disease. Naturally acquired immunity: gain of adaptive immunity through normal events, such as exposure to an infectious agent. Immunization mimics same events, protecting disease against artificially acquired immunity. Active immunity: result of an immune response in a person who has been exposed to an antigen. B and t cells are activated and they then multiple, giving the person lasting protection due to immunological memory. Naturally from actual infection or artificially from vaccination. Mother"s igg antibodies cross the placenta and protect the fetus. Antibodies remain active in newborn during first few months of life. Infectious disease do not develop in baby until 3-6 months after mother"s antibodies degraded. Result from breast feeding: secretory iga in breast milk protects the digestive tract of child. Artificially acquired passive immunity involves injecting a person with antibodies produced by other people or animals. Prevent disease before or after likely exposure to pathogen.

Related Questions

1) What is the most efficient and cost-effective way to control infectious diseases? A) variolation C) passive immunotherapy using immunoglobulins B) active immunization by vaccination D) immune testing E) autoimmunization 2) Variolation was first used _______ A) to immunize the Chinese against smallpox. B) to protect individuals against the plague during the Middle Ages. C) to spread smallpox throughout the Native American populations. D) to treat individuals exposed to hepatitis. E) for research purposes in the 20th century. 3) Almost a century after Edward Jenner introduced successful vaccination, Louis Pasteur developed vaccine(s) against A) anthrax. B) human cholera. C) rabies. D) influenza. E) both anthrax and rabies. 4) Pathogens may be attenuated for use in vaccines by ______ A) raising the pathogen for several generations in tissue culture cells. B) genetic manipulation. C) treatment with formaldehyde. D) genetic manipulation coupled with treatment with formaldehyde. E) genetic manipulation and/or raising the pathogen for several generations in tissue culture cells. 5) Which of the following statements regarding an inactivated vaccine is FALSE? A) It can be produced with deactivated whole microorganisms. B) It can be produced from antigenic fragments of a pathogen. C) It is safer than an attenuated vaccine. D) It is made from mutated forms of the pathogen. E) It is made from pathogens that cannot replicate. 6) Which of the following substances is commonly used to inactivate microbes before using them for vaccination? A) formaldehyde B) aluminum C) mineral oil D) saponin E) aluminum phosphate 7) What type of vaccine is the hepatitis B vaccine? A) inactivated whole pathogen B) attenuated vaccine C) toxoid vaccine D) a recombinant vaccine composed of a single antigen of the hepatitis virus E) a vaccine produced by treating the virus with formaldehyde 8) An infectious disease researcher isolates the pathogen responsible for an emerging disease. The microbe is grown in the lab for many generations. A preparation of the laboratory-grown microbe is treated with ionizing radiation and then tested for its potential as a vaccine. What type of vaccine is this? A) attenuated B) subunit C) combination D) toxoid E) inactivated whole 9) OPV, the attenuated oral poliovirus vaccine, is no longer administered in the U.S.A. because it A) is very toxic. B) does not provide good immunity. C) can revert to wild-type virulence. D) can be spread to contacts. E) can be spread to contacts and can revert to wild-type virulence. 10) Hybridomas are factories for antibodies and are produced by _____ A) combining two virus-infected cells. B) fusing plasma cells with myeloma cells. C) repeated culture of a pathogen until it loses its virulence. D) combining a viral infected cell with a bacterial infected cell. E) combining two bacterial infected cells. 11) The study and diagnosis of antigen-antibody interactions in the blood is known as _____ A) immunology. B) hematology. C) serology. D) cytology. E) histology. 12) Which type of antibody assay is represented in this figure? A) an indirect ELISA C) an indirect immunofluorescence assay B) a direct ELISA D) a western blot E) an immunodiffusion assay 13) Titration is a serological procedure that A) identifies the causative microbe of an infectious disease. B) determines the amount of an antibody in the blood. C) must be done before the western blot test to diagnose HIV. D) is used for blood grouping. E) has been replaced by genetic engineering in isolating the antigen of a pathogen. 14) A woman uses a home pregnancy test kit that tests for hCG hormone in urine. She knows this is a type of antibody assay from the kit brochure. Antibodies reacting with the hormone produce two lines on the test strip. What specific type of antibody assay does this represent? A) a direct immunofluoresence test C) an immunochromatographic assay B) a complement fixation test D) an ELISA E) a neutralization assay 15) The complement fixation test uses red blood cells as the target for complement activation. Test serum containing antibodies is combined with a known amount of antigen in a tube, and then the RBCs and antibodies against the RBCs are added. A positive result for the complement fixation test would be A) a line of precipitate near the bottom of the tube. C) loss of color in the tube. B) a cloudy solution in the tube. D) a fluorescent precipitate. E) a solution that is clear due to precipitation of RBCs.

lilaccod196

MICROM 301 Lecture Notes - Lecture 16: Hepatitis B Immune Globulin, Passive Immunity, Immunity (Medical)

Document Summary

Get access

Related Documents

MICROM 301 Chapter 18.1:

MICROM 301 Lecture Notes - Lecture 3: Western Blot, Iron Lung, Neisseria

MICROM 301 Chapter 18.2:

Related Questions